[PDF][PDF] Quantitative fluoroestradiol positron emission tomography imaging predicts response to endocrine treatment in breast cancer
…, EK Schubert, LK Dunnwald, KA Krohn, DA Mankoff - J Clin Oncol, 2006 - academia.edu
Purpose In breast cancer,[18F] fluoroestradiol (FES) positron emission tomography (PET)
correlates with estrogen receptors (ER) expression and predicts response to tamoxifen. We …
correlates with estrogen receptors (ER) expression and predicts response to tamoxifen. We …
Tumor-Specific Positron Emission Tomography Imaging in Patients: [18F] Fluorodeoxyglucose and Beyond
Biochemical and molecular imaging of cancer using positron emission tomography (PET)
plays an increasing role in the care of cancer patients. Most clinical work to date uses the …
plays an increasing role in the care of cancer patients. Most clinical work to date uses the …
[PDF][PDF] Carbon-11-thymidine and FDG to measure therapy response
AF Shields, DA Mankoff, JM Link… - Journal of Nuclear …, 1998 - Soc Nuclear Med
MATERIALS AND METhODS Patients We evaluated six patients (6 men; age range 45—
69yr; mean age 60 yr), four with small cell lung cancer and two with sarcomas. Cancer was …
69yr; mean age 60 yr), four with small cell lung cancer and two with sarcomas. Cancer was …
Progress and promise of FDG-PET imaging for cancer patient management and oncologic drug development
…, J O'shaughnessy, KZ Guyton, DA Mankoff… - Clinical Cancer …, 2005 - AACR
2-[ 18 F]Fluoro-2-deoxyglucose positron emission tomography (FDG-PET) assesses a
fundamental property of neoplasia, the Warburg effect. This molecular imaging technique offers a …
fundamental property of neoplasia, the Warburg effect. This molecular imaging technique offers a …
Consensus recommendations for the use of 18F-FDG PET as an indicator of therapeutic response in patients in National Cancer Institute Trials
…, AA Lammertsma, S Larson, DA Mankoff… - Journal of Nuclear …, 2006 - Soc Nuclear Med
Despite the increasing use of 18F-FDG PET as a biomarker for predicting therapeutic response,
there are no widely accepted standardized protocols for using 18F-FDG PET as a tool …
there are no widely accepted standardized protocols for using 18F-FDG PET as a tool …
Hypoxia and Glucose Metabolism in Malignant Tumors: Evaluation by [18F]Fluoromisonidazole and [18F]Fluorodeoxyglucose Positron Emission Tomography …
JG Rajendran, DA Mankoff, F O'Sullivan… - Clinical cancer …, 2004 - AACR
Purpose: The aim of this study is to compare glucose metabolism and hypoxia in four different
tumor types using positron emission tomography (PET). F-labeled fluorodeoxyglucose (…
tumor types using positron emission tomography (PET). F-labeled fluorodeoxyglucose (…
Blood flow and metabolism in locally advanced breast cancer: relationship to response to therapy
DA Mankoff, LK Dunnwald, JR Gralow… - Journal of Nuclear …, 2002 - Soc Nuclear Med
Locally advanced breast cancer (LABC) is commonly treated with neoadjuvant chemotherapy
followed by definitive surgery. The factors influencing the response of LABC to presurgical …
followed by definitive surgery. The factors influencing the response of LABC to presurgical …
A definition of molecular imaging
DA Mankoff - The Journal of Nuclear Medicine, 2007 - search.proquest.com
To assist with the understanding of molecular imaging in clinical care, statements were
developed that can be used to help communicate the importance of molecular imaging:* …
developed that can be used to help communicate the importance of molecular imaging:* …
Phase II study of daily sunitinib in FDG-PET–positive, iodine-refractory differentiated thyroid cancer and metastatic medullary carcinoma of the thyroid with functional …
LL Carr, DA Mankoff, BH Goulart, KD Eaton… - Clinical Cancer …, 2010 - AACR
Purpose: We conducted a phase II study to assess the efficacy of continuous dosing of
sunitinib in patients with flurodeoxyglucose positron emission tomography (FDG-PET)–avid, …
sunitinib in patients with flurodeoxyglucose positron emission tomography (FDG-PET)–avid, …
[HTML][HTML] Hyperpolarized 13C MRI: path to clinical translation in oncology
…, KR Keshari, A Kjaer, C Laustsen, DA Mankoff… - Neoplasia, 2019 - Elsevier
This white paper discusses prospects for advancing hyperpolarization technology to better
understand cancer metabolism, identify current obstacles to HP (hyperpolarized) 13 C …
understand cancer metabolism, identify current obstacles to HP (hyperpolarized) 13 C …